Walleye Capital
JBIO

Walleye Capital’s Jade Biosciences JBIO Stock Holding History

Walleye Capital’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.12M Buy
+365,272
New +$7.62M 0.03% 567
2024
Q2 		– Sell
-1,558
Closed -$1.61M – 5574
2024
Q1 		$1.61M Buy
+1,558
New +$1.19M ﹤0.01% 2155

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Walleye Capital's JBIO Position: Q2 2026 in Review

Walleye Capital opened a new position in Jade Biosciences (JBIO) in Q2 2026: 365,272 shares worth $8.12M. The stake represents 0.03% of the portfolio and ranks #567 among its holdings. This is a return to the name: Walleye Capital previously reported a position in JBIO as recently as Q1 2024.

Walleye Capital first reported a position in JBIO in Q1 2024 and has held it in 2 quarters since. 153 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Walleye Capital held 365,272 shares of Jade Biosciences worth $8.12M as of Q2 2026.
  • Jade Biosciences was a new Walleye Capital position in Q2 2026.
  • Jade Biosciences made up 0.03% of Walleye Capital's portfolio in Q2 2026, its #567 holding.
  • Walleye Capital first reported a position in Jade Biosciences in Q1 2024 and has held it in 2 quarters since.
  • 153 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.